Targeted gene correction with 5′ acridine-oligonucleotide conjugates

Oligonucleotides

Volumn 17, Issue 2, 2007, Pages 258-263

  De Piedoue G ^a   Andrieu Soler, C ^b   Concordet, J P ^b   Maurisse, R ^a,c   Sun, J S ^d   Lopez, B ^e   Kuzniak, I ^a   Leboulch, P ^a,f   Feugeas, J P ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b INSTITUT COCHIN   (France)

^c Medicen   (France)

^d DNA Therapeutics   (France)

^e INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE; GREEN FLUORESCENT PROTEIN; INTERCALATING AGENT; OLIGONUCLEOTIDE; PSORALEN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; BINDING AFFINITY; CHROMOSOME MUTATION; CONJUGATE; CONJUGATION; CONTROLLED STUDY; DNA BINDING; DNA HYBRIDIZATION; DNA REPAIR; GENE MUTATION; GENE TARGETING; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ACRIDINES; FICUSIN; GENE THERAPY; HUMANS; INTERCALATING AGENTS; OLIGONUCLEOTIDES; OLIGONUCLEOTIDES, ANTISENSE; TARGETED GENE REPAIR; TRANSFECTION;

EID: 34547209725     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2007.0074     Document Type: Article

References (25)

1. ANDRIEU-SOLER, C., CASAS, M., FAUSSAT, A. M., GANDOLPHE, C., DOAT, M., TEMPE, D., GIOVANNANGELI, C., BEHAR-COHEN, F., and CONCORDET, J. P. (2005). Stable transmission of targeted gene modification using single-stranded oligonucleotides with flanking LNAs. Nucleic Acids Res. 33, 3733-3742.
2. ARIMONDO, P.B., BOUTORINE, A., BALDEYROU, B., BAILLY, C., KUWAHARA, M., HECHT, S.M., SUN, J.S., GARESTIER, T., and HELENE, C. (2002). Design and optimization of camptothecin conjugates of triple helix-forming oligonucleotides for sequence-specific DNA cleavage by topoisomerase I. J. Biol. Chem. 277, 3132-3140.
3. ASSELINE, U., TOULME, F., THUONG, N.T., DELARUE, M., MONTENAY-GARESTIER, T., and HELENE, C. (1984). Oligodeoxynucleotides covalently linked to intercalating dyes as base sequence-specific ligands. Influence of dye attachment site. EMBO J. 3, 795-800.
4. BORGATTI, M., LAMPRONTI, I., ROMANELLI, A., PEDONE, C., SAVIANO, M., BIANCHI, N., MISCHIATI, C., and GAMBARI, R. (2003). Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites. J. Biol. Chem. 278, 7500-7509.
5. BORGATTI, M., BOYD, D. D., LAMPRONTI, I., BIANCHI, N., FABBRI, E., SAVIANO, M., ROMANELLI, A., PEDONE, C., and GAMBARI, R. (2005). Decoy molecules based on PNA-DNA chimeras and targeting Sp1 transcription factors inhibit the activity of urokinase-type plasminogen activator receptor (uPAR) promoter. Oncol. Res. 15, 373-383.
6. BRUNET, E., CORGNALI, M., PERROUAULT, L., ROIG, V., ASSELINE, U., SORENSEN, M.D., BABU, B.R., WENGEL, J., and GIOVANNANGELI, C. (2005). Intercalator conjugates of pyrimidine locked nucleic acid-modified triplex-forming oligonucleotides: improving DNA binding properties and reaching cellular activities. Nucleic Acids Res. 33, 4223-4234.
7. CIEPLAK, P., RAO, S.N., HELENE, C., MONTENAY-GARESTIER, T., and KOLLMAN, P.A. (1987). Conformations of duplex structures formed by oligodeoxynucleotides covalently linked to the intercalator 2-methoxy-6-chloro-9-aminoacridine. J. Biomol. Struct. Dyn. 5, 361-382.
8. DE PIEDOUE, G., MAURISSE, R., KUZNIAK, I., LOPEZ, B., PERRIN, A., NEGRE, O., LEBOULCH, P., and FEUGEAS, J. P. (2005). Improving gene replacement by intracellular formation of linear homologous DNA. J. Gene Med. 7, 649-656.
9. HUEN, M.S., LI, X.T., LU, L.Y., WATT, R.M., LIU, D.P., and HUANG, J.D. (2006). The involvement of replication in single stranded oligonucleotide- mediated gene repair. Nucleic Acids Res. 34, 6183-6194.
10. IGOUCHEVA, O., ALEXEEV, V., and YOON, K. (2001). Targeted gene correction by small single-stranded oligonucleotides in mammalian cells. Gene Ther. 8, 391-399.
11. IGOUCHEVA, O., ALEXEEV, V., SCHARER, O., and YOON, K. (2006). Involvement of ERCC1/XPF and XPG in oligodeoxynucleotide-directed gene modification. Oligonucleotides 16, 94-104.
12. KALISH, J.M., and GLAZER, P.M. (2005). Targeted genome modification via triple helix formation. Ann. N. Y. Acad. Sci. 1058, 151-161.
13. MAURISSE, R., FEUGEAS, J.P., BIET, E., KUZNIAK, I., LEBOULCH, P., DUTREIX, M., and SUN, J.S. (2002). A new method (GOREC) for directed mutagenesis and gene repair by homologous recombination. Gene Ther. 9, 703-707.
14. MAURISSE, R., FICHOU, Y., DE SEMIR, D., CHEUNG, J., FEREC, C., and GRUENERT, D.C. (2006). Gel purification of genomic DNA removes contaminating small DNA fragments interfering with polymerase chain reaction analysis of small fragment homologous replacement. Oligonucleotides 16, 375-386.
15. OLSEN, P. A., RANDOL, M., and KRAUSS, S. (2005a). Implications of cell cycle progression on functional sequence correction by short single-stranded DNA oligonucleotides. Gene Ther. 12, 546-551.
16. OLSEN, P.A., RANDOL, M., LUNA, L., BROWN, T., and KRAUSS, S. (2005b). Genomic sequence correction by single-stranded DNA oligonucleotides: role of DNA synthesis and chemical modifications of the oligonucleotide ends. J. Gene Med. 7, 1534-1544.
17. PORTEUS, M.H., and BALTIMORE, D. (2003). Chimeric nucleases stimulate gene targeting in human cells. Science 300, 763.
18. RADECKE, F., PETER, I., RADECKE, S., GELLHAUS, K., SCHWARZ, K., and CATHOMEN, T. (2006). Targeted chromosomal gene modification in human cells by single-stranded oligodeoxynucleotides in the presence of a DNA double-strand break. Mol. Ther. 14, 798-808.
19. RASMUSSEN, F.W., BENDIFALLAH, N., ZACHAR, V., SHIRAISHI, T., FINK, T., EBBESEN, P., NIELSEN, P.E., and KOPPELHUS, U. (2006). Evaluation of transfection protocols for unmodified and modified peptide nucleic acid (PNA) oligomers. Oligonucleotides 16, 43-57.
20. SORENSEN, C.B., KROGSDAM, A.M., ANDERSEN, M.S., KRISTIANSEN, K., BOLUND, L., and JENSEN, T.G. (2005). Site-specific strand bias in gene correction using single-stranded oligonucleotides. J. Mol. Med. 83, 39-49.
21. STEWART, D.A., THOMAS, S.D., MAYFIELD, C.A., and MILLER, D.M. (2001). psoralen-modified, clamp-forming antisense oligonucleotides reduce cellular c-Myc protein expression and B16-F0 proliferation. Nucleic Acids Res. 30, 2565-2574.
22. STEWART, D.A., XU, X., THOMAS, S.D., and MILLER, D.M. (2002). Acridine-modified, clamp-forming antisense oligonucleotides synergize with cisplatin to inhibit c-Myc expression and B16-F0 tumor progession. Nucleic Acids Res. 30, 2565-2574.
23. SUN, J.S., FRANCOIS, J.C., MONTENAY-GARESTIER, T., SAISON-BEHMOARAS, T., ROIG, V., THUONG, N.T., and HELENE, C. (1989). Sequence-specific intercalating agents: intercalation at specific sequences on duplex DNA via major groove recognition by oligonucleotide-intercalator conjugates. Proc. Natl. Acad. Sci. USA 86, 9198-9202.
24. WANG, G., LEVY, D.D., SEIDMAN, M.M., and GLAZER, P.M. (1995). Targeted mutagenesis in mammalian cells mediated by intracellular triple helix formation. Mol. Cell Biol. 15, 1759-1768.
25. WU, X.S., XIN, L., YIN, W.X., SHANG, X.Y., LU, L., WATT, R.M., CHEAH, K. S., HUANG, J.D., LIU, D.P., and LIANG, C.C. (2005). Increased efficiency of oligonucleotide-mediated gene repair through slowing replication fork progression. Proc. Natl. Acad. Sci. USA 102, 2508-2513.